Toxicology testing is a science, which deals with the identification of poisons and controlled substances and their effect on the legal, clinical, and industrial environment. Toxicology testing laboratories perform diagnosis of numerous controlled substances for excessive consumption with the help of suspect samples such as urine, hair, blood, and oral fluids.
North America toxicology laboratories market is estimated to account for US$ 317.1 Mn in terms of value by the end of 2027
North America Toxicology Laboratories Market: Drivers
Increasing awareness about conventional toxicology testing devices is expected to boost growth of North America toxicology laboratories market over the forecast period. The demand for conventional toxicology testing devices is high in the U.S. and Canada, owing to large consumption of controlled substances in these countries. Most of the publically funded toxicology laboratories (forensic laboratories) are dependent on conventional testing equipment. This is due to the high performance offer by these devices at a minimal cost. Toxicology laboratories in hospitals and diagnostic testing centres rely strongly on conventional technologies, due to the cost benefits.
Moreover, availability of cost effective toxicity testing methods is also expected to propel growth of the market. The use of conventional methods such as immunoassay and mass spectrometry in laboratory toxicity testing is more cost-effective over advanced methods such as Polymerase Chain Reaction (PCR), high-performance liquid chromatography (HPLC), and others. For instance, the cost of a single sample test (urine or blood) may vary between US$ 10 and US$ 50 per sample. However, toxicity testing through advanced methods could cost around US$ 100-US$ 150 per sample.
U.S. held dominant position in North America toxicology laboratories market in 2018, accounting for 83.1% share in terms of value, followed by Canada.
Figure 1. North America Toxicology Laboratories Market Value (US$ Mn), by Region, 2018
North America Toxicology Laboratories Market: Restraints
Introduction of point-of-care toxicology testing devices is expected to hamper growth of North America toxicology laboratories market. Increasing abusive consumption of controlled substances has led to high demand for handheld toxicology testing devices. This in turn has led companies to focus on developing point-of-care toxicology testing devices. Commercialization of point-of-care toxicology testing devices would eventually capture the market share of conventional toxicology laboratories, which in turn may adversely impact the market growth. For instance, in April 2019, Neogen launched a portable version of its Raptor Integrated Analysis Platform that offers the option of performing mycotoxin testing in the laboratory — or wherever a tester may choose.
Moreover, limited efficacy of conventional techniques is also expected to hinder growth of the market. Conventional toxicology testing requires an individual to undergo a confirmatory test, owing to its limited efficacy. This in turn increases the overall cost of the technique. Such limited efficacy of conventional toxicity testing techniques has led to their decreasing demand in crucial drug testing in which least amount of sample is collected.
North America Toxicology Laboratories Market: Opportunities
Increasing expenditure by the government agencies on toxicity testing to control consumption of illegal drugs is expected to offer lucrative growth opportunities for players in North America toxicology laboratories market. For instance, in December 2019, The Florida Department of Health announced that US$ 650,000 in legislatively-appropriated funds was awarded to four Florida universities for new project to test humans for health risks from toxic blue-green algae on Treasure Coast.
Moreover, integration of toxicology results with cloud computing technologies is also expected to boost growth of the market. The test results obtained from the forensic sample contain confidential information that needs to be circulated across various authorities. Such confidential results are interpreted and stored in toxicology library with the help of cloud storage technologies. Presently, there is minimal adoption of such cloud competing technologies in the toxicology testing industry. However, these technologies hold lucrative growth opportunities in the market in the near future, owing to increasing number of samples tested for abusive consumption.
Amphetamines segment in North America toxicology laboratories market was valued at US$ 33.3 Mn in 2018 and is expected to reach US$ 92.9 Mn by 2027 at a CAGR of 11.4% during the forecast period.
Market Trends/Key Takeaways
The market is witnessing increasing commercialization of automated toxicity testing systems for drug toxicity testing, especially for controlled substances. Majority of laboratory equipment manufacturers are concentrating on the development of highly advanced testing systems, which would reduce the overall time taken for carrying out drug testing. For instance, in July 2019, InSphero AG launched 3D InSight Human Liver Disease Discovery Platform for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The platform enables scalable in vitro drug efficacy assessment, screening, combinatorial testing as well as the study of complex NASH pathophysiology.
The market is also witnessing several partnership and collaboration activities among key players. For instance, in June 2019, Draper collaborated with Bristol-Myers Squibb to develop a unique liver tissue model for screening the toxicity of drugs.
North America Toxicology Laboratories Market: Competitive Landscape
Major players operating in North America toxicology laboratories market include, InSphero AG, The Charles Stark Draper Laboratory, Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio Rad Laboratories Inc., Eurofins Scientific, Neogen Corporation, Enzo Life Sciences, Inc., and Vala Sciences Inc.
North America Toxicology Laboratories Market: Key Developments
Key players in the market are focused on expanding services to enhance their market share. For instance, in January 2020, Agilent Technologies Inc. announced the latest implementation of its mutual compatibility philosophy through which joint customers of Agilent Technologies and Thermo Fisher Scientific can choose a chromatography data system from either company—Agilent OpenLab CDS or Thermo Fisher Chromeleon—to control analytical instruments from both organizations.
Key players in the market are also focused on product approval and launch to expand their product portfolio. For instance, in April 2019, Bio-Rad Laboratories, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Bio-Rad’s IH-500, an automated random access system for blood typing and screening.
Toxicology testing refers to the identification and characterization of toxicity of drugs which can have adverse effect and help in guiding individual patient during the course of treatment. Toxicology testing laboratories perform diagnosis of numerous controlled substances for excessive consumption with the help of suspect samples such as urine, hair, blood, and oral fluids.
Key features of the study: